Case Study
Healthcare

NHS England's PAS 2090 Pilot Use Case

This case study explores how PAS 2090 can support health systems collaborate with suppliers to decarbonise their medicines supply chain.

Read full case study

Case Overview

Integrating PAS 2090 across the National Health Service (NHS)

Enabling the NHS, its pharmaceutical suppliers, academics and other stakeholders to undertake product-level LCAs using clear and consistent rules. It reduces ambiguity, improves LCA reliability and will accelerate data collection and interpretation.

Read full case study

The Challenge

Lack of a harmonised method to measure and report medicines’ environmental impact.

The NHS has committed to achieving net zero by 2045; however, 62% of its emissions originate from its supply chain, with over a quarter linked to medicines and prescribing. Data maturity and availability across the pharmaceutical supply chain remain highly variable, and there has been no consistent way to measure and report environmental impacts. This limited the NHS’s ability to understand emissions hotspots and drivers within the pharmaceutical supply chain, restricting data-driven decision-making and effective collaboration with suppliers.

The Solution

Implementing PAS 2090 to provide a consistent framework for lifecycle assessments, enabling standardised measurement, reporting, and data-driven decarbonisation

PAS 2090 introduced a consistent framework to assess the climate change impact of pharmaceutical products, defining clear and consistent rules for lifecycle assessments. It standardised data requirements, transparency and reporting, improving reliability and comparability. This enables the NHS to generate insight into the drivers of emissions, identify opportunities to collaborate, and support adoption of lower carbon alternatives, creating a data-driven pathway to prioritise decarbonisation actions.

Contact Us